Industry Satellite Symposia Sessions

Immunotherapy

← Back to the Areas of Interest  

INVITATION

AstraZeneca - Improving outcomes with immuno-oncology: Evolving treatment paradigms for first-line ES-SCLC and unresectable stage III NSCLC

View the full invitation

INVITATION

MSD -Extending Longer-Term survival in Lung Cancer and HNSCC with IO and Novel Combinations

View the full invitation

INVITATION

AstraZeneca - Emerging immuno-oncology combinations for the treatment of HCC

View the full invitation